Contineum Therapeutics (CTNM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

15.810
-0.210-1.31%

Close May 10 16:00 ET

15.500
-0.310-1.96%

Post 17:09 ET

397.32MMarket Cap17.49P/E (TTM)

Full Hours

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Stifel, Morgan Stanley Bullish on Newly Public Contineum
Seeking AlphaApr 30 13:10 ET
Express News | Contineum Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $29
ReutersApr 30 06:44 ET
Contineum Therapeutics Price Target Announced at $29.00/Share by Stifel
Contineum Therapeutics Price Target Announced at $29.00/Share by Stifel
Dow JonesApr 30 05:30 ET
Contineum Therapeutics Initiated at Overweight by Morgan Stanley
Contineum Therapeutics Initiated at Overweight by Morgan Stanley
Dow JonesApr 30 05:25 ET
Express News | Morgan Stanley Initiates Coverage On Contineum Therapeutics With Overweight Rating, Announces Price Target of $25
BenzingaApr 30 05:15 ET
Contineum Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/30/2024 58.83% Morgan Stanley → $25 Initiates Coverage On → Overweight
BenzingaApr 30 05:13 ET

Comments

Pinchie McPincher

Apr 19 16:23

$Contineum Therapeutics(CTNM.US)$what am i missing?

Jaguar8

Apr 5 11:56

$Contineum Therapeutics(CTNM.US)$
NEWS
Contineum Therapeutics, Inc. announces pricing of IPO, offering 6,875,000 shares of Class A common stock at $16.00 per share, expecting gross proceeds of $110.0 million. Shares to trade on Nasdaq under symbol 'CTNM'.